Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia

BACKGROUND: Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable point-of-care G6PD diagnostic tests. OBJECTIVES: To...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Wojnarski, Bertha, Lon, Chanthap, Sea, Darapiseth, Sok, Somethy, Sriwichai, Sabaithip, Chann, Soklyda, Hom, Sohei, Boonchan, Threechada, Ly, Sokna, Sok, Chandara, Nou, Samon, Oung, Pheaktra, Kong, Nareth, Pheap, Vannak, Thay, Khengheang, Dao, Vy, Kuntawunginn, Worachet, Feldman, Mitra, Gosi, Panita, Buathong, Nillawan, Ittiverakul, Mali, Uthaimongkol, Nichapat, Huy, Rekol, Spring, Michele, Lek, Dysoley, Smith, Philip, Fukuda, Mark M., Wojnarski, Mariusz
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994100/
https://ncbi.nlm.nih.gov/pubmed/32004348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0228207
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi